Bayer Articles
Gen-Probe wins in viral diagnostic dispute with Bayer
11 April 2005
Barr prevails in Bayer Cipro patent dispute
11 April 2005
Eric Pauwels to join TKT
4 April 2005
Bayer/Onyx anti-cancer drug looking good
28 March 2005
Bayer's Adalat efficacy shown in ACTION trial
28 March 2005
Editor's views on DTC advertising
28 March 2005
Heart attack victims benefit from Sanofi's Plavix
14 March 2005
Stock Commentary - Europe
14 March 2005
Bayer and Onyx start Ph II trial of cancer drug
14 March 2005
Bayer Technology Services acquires Zeptosens
14 March 2005
Stock Commentary - Europe
7 March 2005
NicOx drug superior to aspirin; new data
7 March 2005
Stock Commentary - Europe
28 February 2005
Bayer says FDA committee supports Aleve safety
28 February 2005
Ventiv Pharma enters deal with Bayer Diabetes Care Division
21 February 2005
Stock Commentary - Europe
21 February 2005
German pharma eyes Pfizer cost-cutting
21 February 2005
Stock Commentary - Europe
14 February 2005
Novartis considers limited initial approval of Prexige in the USA
14 February 2005
Bayer submits naproxen safety profile to FDA
14 February 2005
Hitch for Pennsylvania drug pricing suit
14 February 2005
Stock Commentary - Europe
7 February 2005
Migrainers snot getting most effective therapy: Datamonitor
7 February 2005
Bayer wins FDA OK for two hepatitis tests
7 February 2005
Bayer and Nektar collaborate on novel Cipro
31 January 2005
Stock Commentary - Europe
31 January 2005
FDA approves Hi-Tech's ciprofloxacin ophthalmic solution
31 January 2005
Bayer updates on Lipobay settlements
31 January 2005
Higher ulcer risk from Plavix, study shows
31 January 2005
Highlights of pharmaceutical mergers and acquisitions in 2004
24 January 2005
Safety concerns over COX-2s deepen
24 January 2005
Stock Commentary - European
17 January 2005
Possible Crestor link with patient death
17 January 2005
Stock Commentary - Europe
10 January 2005
Bristol-Myers Squibb in talks to sell analgesics business?
10 January 2005
Roche 3.6B SwFr OTC sale to Bayer completes
10 January 2005
Novartis and Bayer Vital form Emselex alliance
10 January 2005
HIV/AIDS group urges ban on US DTC ads
10 January 2005
NIH: no higher CV risk seen in ADAPT study with Celebrex
10 January 2005
GW's cannabis drug gets Qualifying Notice
10 January 2005
S-P to pay $6M+ to Pa Medicaid program in Claritin pricing case
10 January 2005
Bayer and Stada hit by FDA warning on naproxen
10 January 2005
Positive new data for Bayer/GSK's Levitra
20 December 2004
Stock Commentary - Europe
20 December 2004
Pharmagene modifies alliance with Bayer Healthcare
20 December 2004
Bayer divests plasma business for $590M
20 December 2004
B-MS seeks clearance for Pravachol OTC
20 December 2004
Future of parallel drug trade in enlarged Europe
20 December 2004
Bayer HealthCare sheds 560 jobs
13 December 2004
Stock Commentary - Europe
13 December 2004
Brand-name pharma striking "authorized generics" deals
13 December 2004
Bayer and GlaxoSmithKline launch ED campaign
13 December 2004
Stock Commentary - Europe
15 November 2004
Collaborative alliance for aspirin resistance testing
15 November 2004
BAY 43-9006 can be used with other drugs
8 November 2004
FDA Orphan Drug status for BAY 43-9006
8 November 2004
Bayer and CTT settle patent dispute
1 November 2004
BAY 43-9006 to be filed on Ph III results
1 November 2004
Positive results for deCODE's DG031
25 October 2004
Is biotech approaching a golden era? Firms showcase technologies at BioPartnering Euro
25 October 2004
Rapid uUTI symptom improvement with Bayer's Cipro XR
25 October 2004
Stock Commentary - Europe - week to Oct 4
11 October 2004
Bayer sets allotment for Lanxess shares
11 October 2004
UK firms Argenta and Etiologics marry
11 October 2004
Positive new data for Bayer/Onyx' BAY 43-9006
4 October 2004
Bayer licenses Seattle Genetics' ADC technology
4 October 2004
Anti-platelet effects of kiwi fruit revealed
4 October 2004
Bayer Technology Services buys Ehrfeld Mikrotechnik
4 October 2004
Stock Commentary - Europe
27 September 2004
Bayer settles 2,861 Lipobay/Baycol cases for $1.1B
27 September 2004
Zuellig Pharma to lose Vietnam monopoly?
27 September 2004
Stock Commentary - Europe
20 September 2004
Stock Commentary - New York
20 September 2004
Editor's views on AstaZeneca Exanta woes and Bayer/S-P deal
20 September 2004
Spectrum gains first ANDA approval, for ciprofloxacin
20 September 2004
Bayer and Schering-Plough form strategic pharmaceuticals alliance
20 September 2004
Bayer under fire from DZ bank and press
20 September 2004
Indian biotech firms eye Germany
13 September 2004
In August, biotech emerges from doldrums, but uncertainty persists: Burrill review
13 September 2004
Stock Commentary - Europe
6 September 2004
Bayer sees shares dip on mixed 2nd-qtr
6 September 2004
Letter from the Editor
6 September 2004
Lilly ICOS claims increased market share for Cialis
30 August 2004
Apax Partners forms Aerovance via spin out of Bayer projects
30 August 2004
Stock Commentary - Europe
23 August 2004
Bayer Biologicals debuts awards program
23 August 2004
FDA OK for Bayer's 2nd hepatitis B assay
23 August 2004
Bayer to sell blood unit to Cerebus for 500M euros?
16 August 2004
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
